FP5Individual fellowship2001–2003
Targeted organometallic anticancer agents: design, synthesis and mechanism of action
FP5 — Improving Human Research Potential
- Duration
- 2001-03-01 → 2003-02-28
- EU contribution
- €114,272
- Participants
- 1
- Scheme
- RGI
Lines connect the coordinator with its partners.
Participants
- UNIVERSITY OF EDINBURGH · EDINBURGHCoordinatorUnited Kingdom
Links
Data: CORDIS, © European Union